These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. In vitro plasma protein binding determination of flunarizine using equilibrium dialysis and liquid chromatography-tandem mass spectrometry. Lin ZJ; Musiano D; Abbot A; Shum L J Pharm Biomed Anal; 2005 Apr; 37(4):757-62. PubMed ID: 15797798 [TBL] [Abstract][Full Text] [Related]
6. High-performance liquid chromatographic assay of flunarizine in plasma and its application to biopharmaceutic investigations. Nieder M; Jaeger H J Chromatogr; 1986 Aug; 380(2):443-9. PubMed ID: 3760075 [No Abstract] [Full Text] [Related]
7. Pharmacokinetic profile of topical flunarizine in rabbit eye and plasma. Maltese A; Bucolo C J Ocul Pharmacol Ther; 2003 Apr; 19(2):171-9. PubMed ID: 12804062 [TBL] [Abstract][Full Text] [Related]
8. Assay of a calcium antagonist (PU 122) in plasma by gas chromatography. Marzo A; Treffner E; Meroni G; Ripamonti M; Pelloso R; Lucarelli C J Chromatogr; 1989 Dec; 497():296-301. PubMed ID: 2625466 [No Abstract] [Full Text] [Related]
9. Sensitive gas chromatographic method for the determination of cinnarizine and flunarizine in biological samples. Woestenborghs R; Michielsen L; Lorreyne W; Heykants J J Chromatogr; 1982 Oct; 232(1):85-91. PubMed ID: 7142341 [TBL] [Abstract][Full Text] [Related]
10. Flunarizine for treatment of partial seizures: results of a concentration-controlled trial. Pledger GW; Sackellares JC; Treiman DM; Pellock JM; Wright FS; Mikati M; Sahlroot JT; Tsay JY; Drake ME; Olson L Neurology; 1994 Oct; 44(10):1830-6. PubMed ID: 7936231 [TBL] [Abstract][Full Text] [Related]
11. Determination of the calcium antagonist flunarizine in biological fluids by gas-liquid chromatography. Flor SC J Chromatogr; 1983 Feb; 272(2):315-23. PubMed ID: 6833428 [TBL] [Abstract][Full Text] [Related]
12. Flunarizine. A reappraisal of its pharmacological properties and therapeutic use in neurological disorders. Todd PA; Benfield P Drugs; 1989 Oct; 38(4):481-99. PubMed ID: 2684591 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics and pharmacodynamics of flunarizine in multimorbid, geriatric patients with vertigo]. Rolzhäuser HP; Oestreich W; Seiler KU; Peters T; Platt D; Jorisch D Arzneimittelforschung; 1991 Feb; 41(2):109-14. PubMed ID: 2043170 [TBL] [Abstract][Full Text] [Related]
15. GLC determination of chlorphenesin carbamate in serum. Kaiser DG; Shaw SR J Pharm Sci; 1974 Jul; 63(7):1094-7. PubMed ID: 4852199 [No Abstract] [Full Text] [Related]
16. Clinical treatment of epilepsy with calcium entry blockers. Overweg J; Binnie CD Funct Neurol; 1986; 1(4):539-41. PubMed ID: 3609880 [TBL] [Abstract][Full Text] [Related]
17. The use of flunarizine in pediatric epilepsy. Cavazzuti GB; Galli V; Benatti A Funct Neurol; 1986; 1(4):551-4. PubMed ID: 3609882 [TBL] [Abstract][Full Text] [Related]
18. Atypical antipsychotic profile of flunarizine in animal models. Tort AB; Dall'Igna OP; de Oliveira RV; Mantese CE; Fett P; Gomes MW; Schuh J; Souza DO; Lara DR Psychopharmacology (Berl); 2005 Jan; 177(3):344-8. PubMed ID: 15290004 [TBL] [Abstract][Full Text] [Related]
19. Improved direct injection method and extractive methylation method for determination of valproic acid in serum by gas chromatography. Nishioka R; Takeuchi M; Kawai S; Nakamura M; Kondo K J Chromatogr; 1985 Jul; 342(1):89-96. PubMed ID: 3930549 [TBL] [Abstract][Full Text] [Related]
20. Effects of flunarizine therapy on intractable epilepsy. Nakane Y; Seino M; Yagi K; Kaji S; Yamauchi T Arzneimittelforschung; 1989 Jul; 39(7):793-8. PubMed ID: 2675853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]